Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.
about
Impact of selective platelet inhibition in reducing cardiovascular risk - role of vorapaxarClinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosisCurrent antiplatelet treatment strategy in patients with diabetes mellitus.Increased Benefit With Vorapaxar Use in Patients With a History of Myocardial Infarction and Diabetes Mellitus: What the Data Show Us.Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsRole for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside.Vorapaxar: a review of its use in the long-term secondary prevention of atherothrombotic events.Investigational new drugs for the treatment of acute coronary syndrome.Review of vorapaxar for the prevention of atherothrombotic events.Vorapaxar in the secondary prevention of atherothrombosis.Percutaneous Coronary Intervention: 2015 in Review.Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease.Targeting PAR1: Now What?Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention.Platelets: an outlook from biology through evidence-based achievements in critical care.Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease.Vorapaxar in secondary prevention: where we stand.Vorapaxar treatment reduces mesangial expansion in streptozotocin-induced diabetic nephropathy in mice.Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease
P2860
Q26745754-D575BA11-59D2-4699-BF81-5C955E514E2DQ26783034-DF010C60-FCC0-4B37-B28B-6F7553C6E97DQ35544048-8C758630-4BEE-4579-B7A2-46C7967CE73BQ36094523-D2ABE9C5-91F2-4F31-97DA-8E105EBD0C32Q37011769-4991F81F-57E0-4535-BAF5-83EF5E5D2F03Q38402334-82AD8BB9-B308-4615-9CC7-C03BBBD868F3Q38431157-17D08D4A-C9AB-4374-B165-32183FBF37D3Q38594609-0171B80B-FE7B-46B4-B740-5DEE55F54579Q38610947-A43B5B31-2EFE-4E3C-8AA8-E6D4DBF31D05Q38630968-B31F43C1-07F5-4BA5-A0C8-32452ABD36CDQ38728869-4EBA468F-EF2F-43B3-B49B-E137E1E969D4Q38773641-DF6F8B50-2BCF-42A3-9CFC-2EF625C28BDCQ39338913-FD7F89A1-050F-4858-B3EF-74AD4C3AEA62Q41250240-A9917D2B-91E9-4C23-BE06-1F56855C633EQ47178294-87B1909D-3072-46C3-8B85-53E3390E7E01Q47676770-7D8F0F7F-DA93-4E7C-8450-4A36DE0EED8BQ48293958-391A2663-A3AD-474B-B5C4-A2E3D3189860Q54974290-40765035-386E-4E79-B29A-9C67CF52F9E7Q56384060-AD65F04B-E274-449A-B3C2-7729DE31401A
P2860
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Vorapaxar in patients with dia ...... ischemic events-TIMI 50 trial.
@ast
Vorapaxar in patients with dia ...... ischemic events-TIMI 50 trial.
@en
type
label
Vorapaxar in patients with dia ...... ischemic events-TIMI 50 trial.
@ast
Vorapaxar in patients with dia ...... ischemic events-TIMI 50 trial.
@en
prefLabel
Vorapaxar in patients with dia ...... ischemic events-TIMI 50 trial.
@ast
Vorapaxar in patients with dia ...... ischemic events-TIMI 50 trial.
@en
P2093
P2860
P50
P1433
P1476
Vorapaxar in patients with dia ...... ischemic events-TIMI 50 trial.
@en
P2093
Anthony J Dalby
Benjamin M Scirica
David A Morrow
Dominick J Angiolillo
Marc P Bonaca
Matthew A Cavender
Mikael Dellborg
Sabina A Murphy
Ton Oude Ophuis
P2860
P304
P356
10.1161/CIRCULATIONAHA.114.013774
P407
P577
2015-02-13T00:00:00Z